Degree of health
Supporting Definition: ECOG / WHO scale: -‐ PS = 0 normal activity level; -‐ PS = 1 restricted with strenuous activity, but can do light activity; -‐ PS = 2 active >/= 50% of day; -‐ PS = 3 spends >50% of day in chair or bed; -‐ PS = 4 totally confined to bed Inclusion Criteria: All patients Timing: Baseline 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Clinical Type: Single answer
integer
Baseline tumor factors
Supporting Definition: Pathologic staging preferred, if available pT0: no primary tumor pT1: if not able to select T1a or T1b: Tumor ≤3 cm diameter, surrounded by lung or visceral pleura, without invasion more proximal than lobar bronchus pT1a: Tumor ≤2 cm in diameter pT1b: Tumor >2 cm but ≤3 cm in diameter pT2: if not able to select T2a or T2b: Tumor >3 cm but ≤7 cm, or tumor with any of the following features: Involves main bronchus, ≥2 cm distal to carina. Invades visceral pleura. Associated with atelectasis or obstructive pneumonitis that extends to the hilar region but does not involve the entire lung pT2a: Tumor >3 cm but ≤5 cm pT2b: Tumor >5 cm but ≤7 cm pT3: Tumor >7 cm or any of the following: Directly invades any of the following: chest wall, diaphragm, phrenic nerve, mediastinal pleura, parietal pericardium, main bronchus <2 cm from carina (without involvement of carina), Atelectasis or obstructive pneumonitis of the entire lung. Separate tumor nodules in the same lobe pT4: Tumor of any size that invades the mediastinum, heart, great vessels, trachea, recurrent laryngeal nerve, esophagus, vertebral body, carina, or with separate tumor nodules in a different ipsilateral lobe pTX: Primary tumor cannot be assessed Inclusion Criteria: All patients Timing: After surgery Data Source: Clinical Type: Single answer
integer
Supporting Definition: Pathologic staging preferred, if available pN0: No regional lymph node metastases pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension pN2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s) pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph node(s) pNX: Regional lymph nodes were not assessed Inclusion Criteria: All patients Timing: After surgery Data Source: Clinical Type: Single answer
integer
Treatment Factors
Inclusion Criteria: All patients Timing: After treatment Data Source: Clinical Type: Single answer
integer
Treatment Variables
Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Inclusion Criteria: All patients If answered 'yes' on surgery (SURGERY) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Inclusion Criteria: All patients If answered 'yes' on targeted therapy (TARGETTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients If answered 'yes' on targeted therapy (TARGETTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients If answered 'yes' on targeted therapy (TARGETTX), and no end date is entered (TARGETTXSTOPDATE) Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Inclusion Criteria: All patients If answered 'yes' on chemotherapy (CTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients If answered 'yes' on chemotherapy (CTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients If answered 'yes' on chemotherapy (CTX), and no end date is entered (CTXSTOPDATE) Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Inclusion Criteria: All patients If answered 'yes' on immunotherapy (ITX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients If answered 'yes' on immunotherapy (ITX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients If answered 'yes' on immunotherapy (ITX), and no end date is entered (ITXSTOPDATE) Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Inclusion Criteria: All patients Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Inclusion Criteria: All patients If answered 'yes' on radiotherapy (RTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients If answered 'yes' on radiotherapy (RTX) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: All patients If answered 'yes' on radiotherapy (RTX), and no end date is entered (RTXSTOPDATE) Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Acute complications of treatment
Supporting Definition: Grade III: Requiring surgical, endoscopic, or radiological intervention, with our without general anesthesia Grade IV: Life threatening complication (including CNS complications) requiring IC/ICU management; includes single organ dysfunction and multiorgan dysfunction Source: Annals of Surgery. 250(2):187-196, August 2009. Inclusion Criteria: All patients receiving resectional surgery If answered 'yes' on surgery (SURGERY) Timing: Update at least annually Data Source: Clinical Type: Single answer
integer
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with radiotherapy If answered 'yes' on radiotherapy (RADIOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Inclusion Criteria: Patients with radiotherapy If answered 'Other' on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Free text Response Options: CTCAE grade III-‐IV complication due to radiotherapy
text
Inclusion Criteria: Patients with radiotherapy If answered Cytopenias on CTCAE III-‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with radiotherapy If answered Infection on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with radiotherapy If answered Skin reaction on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with radiotherapy If answered Pneumonitis, cough, dyspnea, other lung toxicity on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with radiotherapy If answered Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with radiotherapy If answered Neuropathy, tinnitus, hearing impaired, other neurologic toxicity on CTCAE III-IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with radiotherapy If answered Acute kidney injury on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with radiotherapy If answered Other on CTCAE III‐IV complications due to radiotherapy (COMPLRAD) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Supporting Definition: A CTCAE v 4 grade III complication or higher means that the patient had to be admitted to the hospital. See http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010‐06‐14_QuickReference_5x7.pdf for a list of domains and grades of complications Inclusion Criteria: Patients with systemic therapy If answered 'yes' on chemotherapy or immunotherapy (CHEMOTX or IMMUNOTX) Timing: Update at least annually Data Source: Clinical Type: Multiple answer
boolean
Inclusion Criteria: Patients with systemic therapy If answered 'Other' on CTCAE III‐IV complications due to systemic therapy (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Free text Response Options: CTCAE grade III-IV complication due to systemic therapy
text
Inclusion Criteria: Patients with systemic therapy If answered Cytopenias on CTCAE grade II-IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with systemic therapy If answered Infection on CTCAE grade II-IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with systemic therapy If answered Skin reaction on CTCAE grade II-IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with systemic therapy If answered Pneumonitis, cough, dyspnea, other lung toxicity on CTCAE grade II‐IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with systemic therapy If answered Oesophagitis, mucositis oral, nausea, vomiting, diarrhea, constipation, other GI toxicity on CTCAE grade II‐IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with systemic therapy If answered Neuropathy, tinnitus, hearing impaired, other neurologic toxicity on CTCAE grade II-IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with systemic therapy If answered Acute kidney injury on CTCAE grade II‐IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Inclusion Criteria: Patients with systemic therapy If answered Other on CTCAE grade II-IV complications (COMPLSYS) Timing: Update at least annually Data Source: Clinical Type: Date by DD/MM/YYYY
date
Survival
Inclusion Criteria: All patients If answered "yes” on the question "indicate if the patient has died" (DEATH) Timing: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Administrative data (Death registry) or clinical Type: Single answer
integer
Supporting Definition: This is needed to calculate the 30 and 90 day treatment related mortality Inclusion Criteria: All patients receiving treatment If answered "yes” on the question "indicate if the patient has died" (DEATH) Timing: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Clinical Type: Single answer
integer
Quality of death
Inclusion Criteria: All patients with end-‐stage disease If answered 'yes' on overall survival (OVERALLSURV) Timing: 1 year post initiation of treatment Tracked ongoing annually for life (when hospital is able to track this ongoing) Data Source: Clinical Type: Numerical value Response Options: Numerical value of number of days
integer